Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.

Wachter R, Haag P, Uhe T, Bacak M, Petroff D, Forkmann M, Eckardt L, Gaspar T, Dinov B, Neef M, Bode K, Seewöster T, Nedios S, Hilbert S, Lerche M, Lindemann F, Spies C, Beimel S, Paiva BTC, Hohendanner F, Tscholl V, Lenarczyk R, Bergau L, Sohns C, Prettin C, Laufs U, Hindricks G, Dagres N, PVI-SHAM-AF Investigators

Open source

DOI
10.1016/s0140-6736(26)01558-8
Published
2026 Sep 12
Container
Lancet (London, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01558-8,
  title = {Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.},
  author = {Wachter R and Haag P and Uhe T and Bacak M and Petroff D and Forkmann M and Eckardt L and Gaspar T and Dinov B and Neef M and Bode K and Seewöster T and Nedios S and Hilbert S and Lerche M and Lindemann F and Spies C and Beimel S and Paiva BTC and Hohendanner F and Tscholl V and Lenarczyk R and Bergau L and Sohns C and Prettin C and Laufs U and Hindricks G and Dagres N and PVI-SHAM-AF Investigators},
  year = {2026},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(26)01558-8},
  url = {https://doi.org/10.1016/s0140-6736(26)01558-8}
}

RIS

TY  - JOUR
TI  - Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.
AU  - Wachter R
AU  - Haag P
AU  - Uhe T
AU  - Bacak M
AU  - Petroff D
AU  - Forkmann M
AU  - Eckardt L
AU  - Gaspar T
AU  - Dinov B
AU  - Neef M
AU  - Bode K
AU  - Seewöster T
AU  - Nedios S
AU  - Hilbert S
AU  - Lerche M
AU  - Lindemann F
AU  - Spies C
AU  - Beimel S
AU  - Paiva BTC
AU  - Hohendanner F
AU  - Tscholl V
AU  - Lenarczyk R
AU  - Bergau L
AU  - Sohns C
AU  - Prettin C
AU  - Laufs U
AU  - Hindricks G
AU  - Dagres N
AU  - PVI-SHAM-AF Investigators
PY  - 2026
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(26)01558-8
UR  - https://doi.org/10.1016/s0140-6736(26)01558-8
ER  - 

APA

R, W., P, H., T, U., M, B., D, P., M, F., L, E., T, G., B, D., M, N., K, B., T, S., S, N., S, H., M, L., F, L., C, S., S, B., BTC, P., F, H., V, T., R, L., L, B., C, S., C, P., U, L., G, H., N, D., & Investigators, P. (2026). Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)01558-8

Source records